CME Group Inc. $CME Shares Sold by CreativeOne Wealth LLC

Key Points

• CreativeOne Wealth LLC reduced its stake in CME Group Inc. by 16.0%, now holding 8,748 shares valued at approximately $2.32 million after selling 1,662 shares in the first quarter.
• Insider Sunil Cutinho sold 11,896 shares of CME Group stock, marking a 40.55% decrease in his ownership, while director William R. Shepard purchased 256 shares, increasing his position slightly.
• CME Group announced a quarterly dividend of $1.25 per share, with an annualized yield of 1.9%, set to be paid on September 25th.

CreativeOne Wealth LLC decreased its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 16.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,748 shares of the financial services provider's stock after selling 1,662 shares during the quarter. CreativeOne Wealth LLC's holdings in CME Group were worth $2,321,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its position in shares of CME Group by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider's stock worth $9,190,661,000 after buying an additional 400,737 shares in the last quarter. Raymond James Financial Inc. grew its position in shares of CME Group by 9.7% during the 1st quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider's stock worth $1,091,401,000 after buying an additional 363,130 shares in the last quarter. Janus Henderson Group PLC grew its position in shares of CME Group by 24.7% during the 4th quarter. Janus Henderson Group PLC now owns 3,135,753 shares of the financial services provider's stock worth $728,260,000 after buying an additional 621,713 shares in the last quarter. Massachusetts Financial Services Co. MA grew its position in shares of CME Group by 29.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider's stock worth $747,744,000 after buying an additional 648,591 shares in the last quarter. Finally, Wellington Management Group LLP grew its position in shares of CME Group by 370.5% during the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock worth $704,068,000 after buying an additional 2,089,935 shares in the last quarter. Institutional investors own 87.75% of the company's stock.

CME Group Stock Down 1.0%

CME Group stock traded down $2.72 during midday trading on Tuesday, reaching $263.79. The company's stock had a trading volume of 1,613,925 shares, compared to its average volume of 2,309,292. The stock's 50-day simple moving average is $275.51 and its 200-day simple moving average is $269.64. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 52-week low of $207.75 and a 52-week high of $290.79. The stock has a market capitalization of $95.07 billion, a P/E ratio of 25.52, a PEG ratio of 4.82 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period last year, the business posted $2.56 earnings per share. The firm's revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 48.40%.

Insider Transactions at CME Group

In related news, Director Charles P. Carey sold 500 shares of the firm's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the sale, the director directly owned 4,900 shares of the company's stock, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.30% of the company's stock.

Analyst Upgrades and Downgrades

CME has been the topic of a number of recent research reports. Citigroup increased their price target on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Piper Sandler upped their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Wall Street Zen cut CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Barclays set a $298.00 price objective on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $261.93.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.